| Oct 2 |
AngioDynamics Q1 2025 Earnings Preview
|
| Sep 30 |
New Strong Buy Stocks for September 30th
|
| Sep 23 |
ANGO Initiates RECOVER-AV Trial for AlphaVac F1885 in Europe
|
| Sep 20 |
AngioDynamics initiates thrombectomy system trial across Europe
|
| Sep 19 |
AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes
|
| Sep 19 |
AngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024
|
| Sep 17 |
This AngioDynamics Insider Increased Their Holding In The Last Year
|
| Sep 9 |
New Strong Buy Stocks for September 9th
|
| Sep 4 |
AngioDynamics Stock Falls Despite CE Mark for Auryon System
|
| Sep 4 |
AngioDynamics wins EU CE mark for Auryon system to treat PAD
|
